RESPONSE AFTER NON-FINAL ACTION - ENTERED
final action
on 10 Sep 2024
Last Applicant/ Owned by
2000 Sierra Point Parkway, Suite 501
Brisbane
CA
94005
Serial Number
98975225 filed on 21st Sep 2023
Registration Number
N/A
Correspondent Address
Connie L. Ellerbach
Filing Basis
1. intent to use
2. intent to use current
Disclaimer
NO DATA
DAY ONE BIOPHARMACEUTICALS
Research, development, and product evaluation of pharmaceutical preparations for the prevention and treatment of cancer; research laboratory analysis and research of drugs and pharmaceutical products; providing medical research information in the fields of oncology, immunotherapy, chemotherapy and combination therapies; research and development services in the fields of oncology, immunotherapy, ch Read More
Classification Information
Class [045]
Personal & Legal & Social Services
Providing patient support services, namely, communicating with patients regarding pharmaceutical drug weekly dosing requirements, impediments to taking pharmaceutical drugs as prescribed, caregiver support, and conducting wellness checkups; providing healthcare patient support services for patients and their families, namely, information, advice, and referrals regarding insurance, benefits, investigations, financial resources, pharmaceutical and drug dosing information, administrative support, and drug shipment information and alternatives all by means of a call center
First Use Date in General
N/A
First Use Date in Commerce
N/A
Class [042]
Computer & Software Services & Scientific Services
Research, development, and product evaluation of pharmaceutical preparations for the prevention and treatment of cancer; research laboratory analysis and research of drugs and pharmaceutical products; providing medical research information in the fields of oncology, immunotherapy, chemotherapy and combination therapies; research and development services in the fields of oncology, immunotherapy, chemotherapy, and combination therapies for the treatment of cancer and tumors; providing medical research information in the fields of oncology, immunotherapy, chemotherapy and combination therapies; scientific advisory services, namely, providing scientific information, advice, and consultancy in the field of cancer treatment; scientific advisory services, namely, providing scientific information, advice, and consultancy in the field of cancer treatment; design, development, research, and testing of new products, namely, drugs and pharmaceuticals for the treatment and/or prevention of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system diseases and disorders; research, development, and medical evaluation of pharmaceutical preparations for the prevention and treatment of cancer; research and development services in the fields of oncology, immunotherapy, chemotherapy, and combination therapies for the treatment of cancer and tumors; scientific advisory services, namely, providing scientific information, advice, and consultancy in the field of cancer treatment; design, development, research, and testing of drugs and pharmaceuticals for the treatment and/or prevention of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders
First Use Date in General
N/A
First Use Date in Commerce
N/A
Class [041]
Education and Entertainment Services
Educational services, namely, providing prescription drug information; educational services, namely, providing prescription drug dosage training; educational services, namely, providing online non-downloadable videos in the field of treatment and diagnosis of tumors and cancer; educational services, namely, providing online non-downloadable videos in the field of treatment and diagnosis of pediatric low-grade glioma; educational services, namely, providing online non-downloadable videos for healthcare service providers, caregivers, and patients in the field of tumors and cancer; educational services, namely, providing online non-downloadable videos for healthcare service providers, caregivers, and patients in the field of pediatric low-grade glioma; providing information regarding tumors and cancer, and pediatric low-grade glioma
First Use Date in General
N/A
First Use Date in Commerce
N/A
Class [036]
Insurance & Financial Services
Healthcare insurance administration services; healthcare insurance administration services, namely, providing benefit verification, authorization and re-authorization support, appeals support, and information regarding benefit updates; providing information about healthcare insurance plans; financial services, namely, assessing sources of and facilitating access by patients and their families to financial support from copay support, patient assistance programs (PAP), patient foundations and organizations; financial services, namely, administration of patient reimbursement programs
First Use Date in General
N/A
First Use Date in Commerce
N/A
Class [005]
Pharmaceutical Products
Pharmaceutical preparations for human use for treating cancer and oncological diseases; pharmaceutical preparation for the prevention and treatment of cancer; pharmaceutical preparations for the treatment of oncological diseases; pharmaceutical preparations and substances for the prevention and treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; medical and veterinary preparations for the delivery of compounds to the body for the treatment and prevention of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders
First Use Date in General
N/A
First Use Date in Commerce
N/A
Mark Details
Serial Number
No 98975225
Mark Type
No Service Mark
Attorney Docket Number
No 37942-00070
44D Filed
No
44D Current
No
44E filed
No
44E Current
No
66A Filed
No
66A Current
No
Current Basis
No
No Basis
No
Design Code(s)
01.05.01 -
Sun, rising or setting (partially exposed or partially obstructed)
Legal History
| Status Date | Action Taken |
|---|---|
| 15th Oct 2024 | DIVISIONAL PROCESSING COMPLETE |
| 11th Oct 2024 | CASE ASSIGNED TO INTENT TO USE PARALEGAL |
| 10th Sep 2024 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| 09th Sep 2024 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| 09th Sep 2024 | TEAS REQUEST TO DIVIDE RECEIVED |
| 09th Sep 2024 | DIVISIONAL REQUEST RECEIVED |
| 09th Sep 2024 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| 06th Jun 2024 | APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED |
| 06th Jun 2024 | APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED |
| 08th Mar 2024 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |